<DOC>
	<DOC>NCT00544557</DOC>
	<brief_summary>This study aims to provide a holistic assessment of patients receiving etanercept in a real-world setting.</brief_summary>
	<brief_title>Study Evaluating The Use Of Etanercept In Patients With Ankylosing Spondylitis</brief_title>
	<detailed_description>Non-interventional study: subjects to be selected according to the usual clinical practice of their physician</detailed_description>
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis, Ankylosing</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Diagnosis of ankylosing spondylitis (AS) Hypersensitivity to etanercept Active infection including chronic or localised infection Sepsis or risk of sepsis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>